Defining Benign/Burnt-Out MS and Discontinuing Disease-Modifying Therapies

OBJECTIVE: To determine whether MS disease-modifying therapies (DMTs) can be safely discontinued in patients aged 50 years or older with suspected benign/burnt-out MS and to define criteria to identify such patients. METHODS: We conducted a retrospective cohort study of 136 patients with suspected b...

Descripción completa

Detalles Bibliográficos
Autores principales: McFaul, Derek, Hakopian, Nektar N., Smith, Jessica B., Nielsen, Allen Scott, Langer-Gould, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057062/
https://www.ncbi.nlm.nih.gov/pubmed/33558306
http://dx.doi.org/10.1212/NXI.0000000000000960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057062/
https://www.ncbi.nlm.nih.gov/pubmed/33558306
http://dx.doi.org/10.1212/NXI.0000000000000960

Ejemplares similares